VOLUME 20 | NUMBER 11 | NOVEMBER 2014 nature medicine l e t t e r S Differentiation of human pluripotent stem cells (hPSCs) into organ-specific subtypes offers an exciting avenue for the study of embryonic development and disease processes, for pharmacologic studies and as a potential resource for therapeutic transplant 1,2 . To date, limited in vivo models exist for human intestine, all of which are dependent upon primary epithelial cultures or digested tissue from surgical biopsies that include mesenchymal cells transplanted on biodegradable scaffolds 3,4 . Here, we generated human intestinal organoids (HIOs) produced in vitro from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) 5, 6 that can engraft in vivo. These HIOs form mature human intestinal epithelium with intestinal stem cells contributing to the cryptvillus architecture and a laminated human mesenchyme, both supported by mouse vasculature ingrowth. In vivo transplantation resulted in marked expansion and maturation of the epithelium and mesenchyme, as demonstrated by differentiated intestinal cell lineages (enterocytes, goblet cells, Paneth cells, tuft cells and enteroendocrine cells), presence of functional brush-border enzymes (lactase, sucrase-isomaltase and dipeptidyl peptidase 4) and visible subepithelial and smooth muscle layers when compared with HIOs in vitro. Transplanted intestinal tissues demonstrated digestive functions as shown by permeability and peptide uptake studies. Furthermore, transplanted HIO-derived tissue was responsive to systemic signals from the host mouse following ileocecal resection, suggesting a role for circulating factors in the intestinal adaptive response [7] [8] [9] . This model of the human small intestine may pave the way for studies of intestinal physiology, disease and translational studies.
l e t t e r S Differentiation of human pluripotent stem cells (hPSCs) into organ-specific subtypes offers an exciting avenue for the study of embryonic development and disease processes, for pharmacologic studies and as a potential resource for therapeutic transplant 1, 2 . To date, limited in vivo models exist for human intestine, all of which are dependent upon primary epithelial cultures or digested tissue from surgical biopsies that include mesenchymal cells transplanted on biodegradable scaffolds 3, 4 . Here, we generated human intestinal organoids (HIOs) produced in vitro from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) 5, 6 that can engraft in vivo. These HIOs form mature human intestinal epithelium with intestinal stem cells contributing to the cryptvillus architecture and a laminated human mesenchyme, both supported by mouse vasculature ingrowth. In vivo transplantation resulted in marked expansion and maturation of the epithelium and mesenchyme, as demonstrated by differentiated intestinal cell lineages (enterocytes, goblet cells, Paneth cells, tuft cells and enteroendocrine cells), presence of functional brush-border enzymes (lactase, sucrase-isomaltase and dipeptidyl peptidase 4) and visible subepithelial and smooth muscle layers when compared with HIOs in vitro. Transplanted intestinal tissues demonstrated digestive functions as shown by permeability and peptide uptake studies. Furthermore, transplanted HIO-derived tissue was responsive to systemic signals from the host mouse following ileocecal resection, suggesting a role for circulating factors in the intestinal adaptive response [7] [8] [9] . This model of the human small intestine may pave the way for studies of intestinal physiology, disease and translational studies.
Because of the complexity of a vascularized hollow organ such as the intestine, the development of an adequate human model for its study and replacement following surgery or pathological processes has proven to be a seemingly impossible task. Methods for studying the human intestine have largely required in vitro culture systems or have relied on animal models to address numerous translational questions, and these do not always translate well in human studies. Traditional intestinal epithelial primary culture techniques were mostly limited to tissue culture technologies, such as organ cultures or intestinal cell lines that do not recapitulate the hierarchy of stem cells to differentiated cells 10 . The recent identification of intestinal stem cells and conditions appropriate for human epithelial culture has overcome many of these obstacles 11, 12 . Successful in vivo engraftment of epithelial cultures, however, remains challenging because of the need for a supporting mesenchyme [13] [14] [15] [16] [17] , as exists in models exposing host mesenchyme following mucosal injury 18, 19 .
In contrast to using primary cell culture approaches that require surgical samples, we recently described an in vitro approach for gen erating HIOs de novo from hPSCs 5 . This technique allows for the robust development of human intestinal tissue, including epithelium with a surrounding and supportive mesenchyme, for in vitro studies. Although HIOs have some intestinal functionality in vitro, this model is insufficient for investigating the impact of broad physiological stimuli on human intestinal tissues. For this reason, we developed an in vivo HIO engraftment model and used it to generate mature, functional human intestinal tissues in vivo that respond to the physio logical stimuli triggered by ileocecal resection.
To establish an in vivo HIO model, we generated HIOs from human ESCs or iPSCs as previously described 5, 6 . The differentiation process took approximately 35 d (Fig. 1a and Supplementary Fig. 1a ) and produced HIOs with columnar intestinal epithelium surrounded by a supporting mesenchyme (Fig. 1b and Supplementary Fig. 1b) . We then embedded the HIOs into type I collagen and transplanted them under the kidney capsule of immunocompromised nonobese diabetic severe combined immunodeficiency interleukin2Rγ null (NSG) mice and allowed them to mature and grow for 6 weeks ( Fig. 1a and Supplementary Fig. 1d,e) . At the time of harvest, the HIOs had grown considerably in size, upwards of 50 to 100fold larger in volume (Fig. 1c,d and Supplementary Figs. 1c and 2a) and were highly vascular ized (Fig. 1c) . Of note, 92.4% of the trans planted HIOs successfully engrafted under the kidney capsule (Supplementary Fig. 1f ). Visual inspection of tissues revealed intesti nal morphology ( Fig. 1d) with mucousfilled lumens and welldeveloped sheets of villi, each with its own central capillary network (Fig. 1e) . Histologically, this engrafted tis sue resembled native human intestine with cryptvillus architecture and underlying laminated submucosal layers including lamina propria, muscularis mucosa and submucosa and outer smooth muscle layers ( Fig. 2a and Supplementary Fig. 2c ). When compared with their in vitro counter parts (data not shown) 5 , the engrafted tissue in vivo appeared more mature and differentiated, with all major intestinal cell lineages, including enterocytes, goblet cells, Paneth cells, enteroendocrine cells and tuft cells, located within appropriate regions of the cryptvillus axis ( Fig. 2b-d and Supplementary Fig. 2d-g ). Paneth cells were located within crypt bases as expected rather than scattered through out the epithelium (Fig. 2b,c) 12 . Transmission electron microscropy (TEM) revealed a brush border with welldeveloped tight junctions similar to that of HIOs in vitro ( Supplementary Fig. 3a) ; however, mature goblet cells and enteroendocrine cells, as seen within the epithelium of engraftments (Supplementary Fig. 3b,c) , were not present in TEM of HIOs in vitro (data not shown). Within the epi thelium, we observed increased relative expression of genes char acteristic of the epithelial cell types when comparing engraftments to HIOs in vitro ( Supplementary Fig. 4a-g ). We found that blood vessels within the engraftment stained positive for mousespecific panendothelial cell antigen (mMECA32) (Fig. 2e) . The engrafted tissue was also actively proliferating within discreet crypts, as revealed by incorporation of 5ethynyl2′deoxyuridine (Edu) (Fig. 2f) . Using transgenic human LGR5 reporter HIOs to trace intestinal stem cells, we found that actively proliferating labeled stem cells were present within the HIOs and localized to the base of the crypts in the engraft ment ( Supplementary Fig. 5a-d) . Additionally, the engrafted tissue expressed the stem cell marker ASCL2 (Supplementary Fig. 5e,f) , and we were able to generate enteroids derived from the epithelium of engraftments, further demonstrating the existence of an intestinal stem cell pool ( Supplementary Fig. 5g-k) . These data suggest that HIOs undergo considerable maturation into mature intestinal tissue following engraftment in vivo.
Crosstalk between the adjacent mesenchyme and intestinal epi thelium is known to play a major role during GI development 20 . It was previously shown that the supporting mesenchyme develops alongside the intestinal epithelium of HIOs in vitro 5 and contains immature populations of subepithelial myofibroblasts, fibroblasts and smooth muscle cells 21, 22 . We investigated whether HIO mesenchyme also developed into more mature, differentiated cell types following engraftment in vivo. The nonepithelial regions of the engrafted tis sue stained positive for the mesenchymal marker vimentin (VIM) and included several laminated subepithelial layers, including dis tinct smooth muscle layers positive for α−smooth muscle actin (αSMA), revealing the mesenchymal contribution of the engraftment (Fig. 2g) . Additionally, dual staining for αSMA and VIM revealed a pericryptal sheath (Fig. 2g) of intestinal subepithelial myofibroblasts (ISEMFs) which are known to support in vitro and in vivo growth of human small intestinal epithelial stem cells 3, 21, 23 . Likewise, the intestinal epithelium has been shown to contribute appropriate sig nals for the development of the subepithelial mesenchymal layers including lamina propria, ISEMFs and muscularis mucosa 20 leading to appropriate laminations of the subepithelium (Fig. 2a,g ). In addi tion to the maturity of smooth muscle layers histologically, relative expression of desmin and αSMA was increased in HIOs engrafted Fig. 4h,i) . TEM of the engraftments revealed smooth muscle cells with parallel ori entation similar to that of adult intestine ( Supplementary Fig. 3d ). These data are consistent with published reports that successful engraftment and maturation of human intestinal tissues requires the presence of a mesenchymal niche [13] [14] [15] [16] 19 . For example, lack of a mesenchymal component has resulted in failure of engraftment 3, 14, 15 , whereas including mesenchymal cells along with epithelium resulted in successful engraftment 3,4,14-17 . As our engraftments contained a variety of mesenchymal cell types, including endothelial cells, we next investigated which components were of human origin and which were from the host. As expected, HIO epithelium was completely of human origin and stained positive for a human nuclear antigen (HuNuc) (Fig. 2h) . In addition, the majority of tissue of mesenchymal origin, including lamina propria, muscularis mucosa, submucosa and smooth muscle layers, also stained positive for HuNuc (Fig. 2i) . In contrast, the majority of blood vessels were of mouse origin as they stained positive for mMECA32 (Fig. 2e) . The blood supply of the engrafted HIO was supported by mouse vas culature, as demonstrated by positive labeling of endothelium with FITCconjugated tomato lectin tail vein injection ( Supplementary  Fig. 6a-d) . Few blood vessels of human origin were positive for humanspecific panendothelial cell antigen in the engraftment, and these were not connected to the mouse vascu lature ( Supplementary Fig. 6e ,f). Lymphatic vessels were of mouse origin and stained positive for mousespecific lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) (Supplementary Fig. 6g ). Engraftment of PSCderived pancreatic progenitor cells has been shown to enhance development of islet cells in vivo 24 . We analyzed the impact of in vivo growth on the maturity of our engraftments at 6 weeks as compared to HIOs in vitro at a similar time point (35 d plus 6 weeks in vitro) by determining the expression of several mark ers of mature epithelium at both the mRNA and protein levels. We observed marked increases in mRNA and/or protein expression of markers characteristic of differentiated enterocytes, including dipep tidyl peptidase 4 (DPPIV), glucose transporter type 2 (GLUT2), sucroseisomaltase (SIM) and villin (VIL), compared to HIOs in vitro (Fig. 3a,b,e,f,i and Supplementary Fig. 4b,g ) 25 . Additionally, we also looked at the brush border enzymes alkaline phosphatase (ALPI) and lactase (LCT), as well as markers of secretory cell types, including enteroendocrine (gastric inhibitory peptide (GIP) and chromogranin A (CHGA)), goblet (mucin 2 (MUC2)) and Paneth cells (lysozyme (LYSO)). For each of these markers, there were also marked increases in mRNA and protein expression in engrafted HIOs (Fig. 3c,d ,g-i and Supplementary Fig. 4c-f) . Therefore, we concluded that in vivo growth promotes maturation of the intestinal tissue.
Given the mature phenotype of engrafted HIOs in vivo, we pos tulated that these tissues might represent a new model to study in vivo physiology of the human gut. We therefore investigated whether engrafted HIOs could respond to physiologic cues elicited by intestinal resection. Humoral factors have been suggested to be involved in the intestinal adaptive response. In rats connected in a parabiotic relationship via vascular anastomosis, surgical resec tion in one rat led to increased intestinal proliferation in the para biotic partner 7 . However, there is no model available to investigate this phenomenon with human intestine. Here, we used a model of ileocecal resection (ICR) 26 in the transplanted mice to investigate whether circulating humoral factors that are stimulated in response to intestinal resection could affect engrafted human intestinal tis sues in the kidney. We randomized mice with HIO engraftments at our 6week time point following transplant to sham (transection and reanastomosis) or ICR groups and quantified morphometric factors associated with intestinal adaptation including crypt depth, villus height, epithelial proliferation, crypt fission and thickness of the circular and longitudinal smooth muscle layers (tunica muscularis) (Fig. 4a) . Adaptation in NSG mice was confirmed with significant differences between sham and ICR groups for villus height, crypt fission ( Fig. 4b-d) , crypt depth and smooth muscle layer thickness (Supplementary Fig. 7a-d) , whereas there was no difference in pro liferative index between sham and ICR groups (data not shown). In engrafted HIOs, ICR increased villus height, crypt fission (Fig. 4e- Values in graphs represent mean ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; t-test. Sham group: n = 4; ICR group: n = 8. l e t t e r S and Supplementary Fig. 7e,f) and proliferative index (Fig. 4h,i) com pared to shamoperated groups. These findings support the hypoth esis that engrafted HIOs respond to humoral factors. In addition, this model may provide insights into the humoral adaptive response following intestinal resection. Functionally, engrafted HIOs expressed active brush border enzymes and exhibited a functional intestinal epithelial barrier, as shown by a permeability assay with FITCdextran ( Supplementary Fig. 8a,b) . The engrafted HIO epithelium was also capable of peptide uptake, reflecting the existence of absorptive func tions (Supplementary Fig. 8c) .
To our knowledge, this is the first report of the development of a functional model for human small intestine in vivo derived from hPSCs. Our study highlights the potential of both ESCs and iPSCs to produce diverse cell types and tissue layers that mature following engraftment. Furthermore, the adaptive response seen in our human grafts following surgical resection in mouse hosts supports the role of humoral factors in this adaptive response and validates the use of our model for further in vivo studies of human small intestine. HIOs may also serve, through further translational research, as a means for the eventual treatment of short bowel syndrome and other gastrointes tinal diseases, as they serve as a way to 'personalize' and bioengineer functional human intestine.
METHODS
Methods and any associated references are available in the online version of the paper. Generation and maintenance of human intestinal organoids. Human intes tinal organoids were generated and maintained as previously described 5, 6 . Human embryonic stem cells and induced pluripotent stem cells were grown in feederfree conditions in sixwell Nunclon surface plates (Nunc) coated with Matrigel (BD Biosciences) and maintained in mTESR1 media (Stem Cell Technologies). For induction of definitive endoderm (DE), human ES or iPS cells were passaged with Dispase or Accutase (Invitrogen) and plated at a density of 100,000 cells per well in a Matrigelcoated, Nunclon surface 24well plate. For Accutase split cells, 10 µM Y27632 compound (Sigma) was added to the media for the first day. Cells were allowed to grow until they reached 80-95% confluence. Cells were then treated with 100 ng ml −1 of Activin A for 3 d as previously described 27 . DE was then treated with hindgut induction medium (RPMI 1640, 2 mM lglutamine, 2% decomplemented FBS, penicillin streptomycin and 100 ng ml −1 Activin A) for 4 d with 500 ng mL −1 FGF4 (R&D) and 3 µM Chiron 99021 (Tocris) to induce formation of midhindgut spheroids. Spheroids were then plated in Matrigel (BD) and maintained in intestinal growth medium (Advanced DMEM/F12, N2, B27, 15 mM HEPES, 2 mM lglutamine, penicillinstreptomycin) supplemented with 100 ng ml −1 EGF (R&D) and 100 ng ml −1 Noggin (R&D) to generate human intestinal organoids (HIOs). Media was changed at 3 d with Noggin removed and then changed twice weekly thereafter. HIOs were replated in fresh Matrigel every 14 d.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.

ACkNoWLEdGMENtS
Generation and characterization of induced pluripotent stem cell lines.
For iPSC generation, fibroblasts were transduced with recombinant VSVGpseudotyped polycistronic lentiviral particles coexpressing reprogramming factors Oct4, Klf4, Sox2, cMyc and dTomato 28 . Nucleofected fibroblasts were then plated on hESCqualified Matrigel, and 3-5 d post transduction, MEF media was replaced with mTeSR1, and cultures were subsequently fed daily with mTeSR1. After ~3 weeks, putative iPSC colonies were identified and exposed to dispase for 5 min. Discrete colonies were manually excised and replated in mTeSR1 on Matrigelcoated dishes. Several lines with typical hESClike mor phology were then expanded independently in mTeSR1 on Matrigelcoated dishes. For passaging, iPSCs were exposed to dispase for 5 min, washed, and gently triturated before replating. iPSC lines were cryopreserved in mFreSR (StemCell Technologies). All cultures were maintained in a 5% CO 2 /air environment. All the experiments with iPSCs in this study were approved by institutional Embryonic Stem Cell Research Oversight (ESCRO).
For analysis of pluripotency marker expression, iPSC cultures were fixed for 10 min at room temperature with 3.7% paraformaldehyde in PBS. Cells were then permeabilized for 10 min with PBS containing 0.5% Triton X100 and incubated for 30 min at room temperature in blocking buffer (10% normal donkey serum in PBS). Antibodies to human Oct4 (Santa Cruz, sc5279) and Nanog (Abcam, ab21624) were diluted in blocking buffer at 1:500 and incu bated with cells overnight at 4 °C. After incubation with fluorescentlabeled secondary antibodies, cultures were visualized using fluorescent microscopy. 4′,6diamidino2phenylindole (DAPI) was used for nuclear counterstaining (Supplementary Fig. 9a,b) . Standard Gbanded karyotype analyses of iPSCs was performed by the Cytogenetics Laboratory at Cincinnati Children's Hospital Medical Center. At least 20 metaphases were analyzed (Supplementary Fig. 9c) . Analysis of in vivo differentiation capacity was assessed with teratoma assays. Undifferentiated iPSCs were injected subcutaneously into immune compro mised NOD/SCID GAMMA C −/− mice. Teratomas formed within 6-12 weeks. Teratomas were excised, fixed, embedded in paraffin, sectioned and stained with H&E for histological examination (Supplementary Fig. 9d ).
Generation of LGR5:eGFP BAC transgenic reporter hESC line. The LGR5: eGFP bacterial artificial chromosome (BAC) transgenic reporter hESC line was generated. In summary, the BAC RP1159F15 was obtained from the Children's Hospital Oakland Research Institute (http://bacpac.chori.org/) and grown in SW10535 cells. A single colony was expanded in LB +cam at 32 °C, and recombineering proteins were induced by incubation at 42 °C for 20 min. The recombination cassette consisted of eGFPFRTPGKgb2neo/ kanFRT, 50bp homology region in LGR5, and a 20bp homology region to peGFPPGKneo. The homology regions were selected to replace the initiator methionine of LGR5 with that of eGFP followed by a bovine growth hormone polyadenylation signal and FRTflanked bifunctional kanamycin/G418 resist ance cassette. The recombination cassette was electroporated into SW105 cells, and cells were selected on plates with cam and kanamycin (kan; 50 µg ml −1 ). Clones were analyzed for properly targeted LGR5 BAC by PCR and confirmed by sequencing and nucleofected into singlecell suspensions of H9 hESCs using the Amaxa Human Stem Cell Nucleofector Starter Kit. Cells were selected in G418 (200 ng ml −1 ) for 2 weeks. G418resistant cells were maintained in antibiotic indefinitely.
Transplantation of human intestinal organoids. NSG mice were kept on antibiotic chow (275 p.p.m. Sulfamethoxazole and 1,365 p.p.m. Trimethoprim; Test Diet). Food and water was provided ad libitum before and after surger ies. A single HIO, matured in vitro for 35 d, was removed from Matrigel, washed with cold phosphatebuffered saline (DPBS; Gibco), and embedded into purified type I collagen (rat tail collagen; BD Biosciences) 12 h before surgery to allow for formation of a solidified gel plug. These plugs were then placed into standard growth media overnight in intestinal growth medium (Advanced DMEM/F12, B27, 15 mM HEPES, 2 mM lglutamine, penicillin streptomycin) supplemented with 100 ng ml −1 EGF (R&D). HIOs were then transplanted under the kidney capsule. Briefly, the mice were anesthetized with 2% inhaled isoflurane (Butler Schein), and the left side of the mouse was then prepped in sterile fashion with isopropyl alcohol and povidineiodine. A small leftposterior subcostal incision was made to expose the kidney. A subcapsular pocket was created and the collagenembedded HIO was then placed into the pocket. The kidney was then returned to the peritoneal cavity and the mice were given an IP flush of Zosyn (100 mg/kg; Pfizer Inc.). The skin was closed in a double layer and the mice were given a subcutaneous injection with Buprenex (0.05 mg/kg; Midwest Veterinary Supply). At 6 weeks following engraftment, the mice were then humanely euthanized or subjected to further experimentation.
Intestinal resections in transplanted mice. Male NSG mice that have previ ously been transplanted with HIOs 6 weeks prior were randomized to ileocecal resection (ICR) or sham operation. Mice were placed on liquid diet (Jevity 1Cal; Abbott) 24-48 h before surgery and were changed from antibiotic chow to liquid antibiotic (200 mg Sulfamethoxazole and 40 mg Trimethoprim oral suspension 5 mL −1 ; HiTech Pharmacal) in their drinking water (0.3 mg mL −1 Trimethoprim) for the remainder of the experiment. Surgeries were com pleted under anesthesia as described above, and the abdomen of the mouse was opened anteriorly to expose the intestine. An average of 13.6 cm of distalmost small intestine was removed in addition to the cecum as previously described 26 . Mice were kept in an incubator at 30 °C for 48 h after surgery and were then euthanized on postoperative day 7.
Culture of transplant-derived enteroids. Human enteroids were generated as previously described 12, 29 . Briefly, engraftments were harvested and opened and pinned with mucosa facing upwards and then rinsed in cold PBS (Gibco). The tissues were then transferred to 2 mM EDTA (EDTA; SigmaAldrich) in PBS and rocked for 30 min on ice. After EDTA chelation, tissues were again washed in cold PBS, and crypts were manually removed from underlying submucosa and then filtered through a 100µm cell strainer (Fisher Scientific). Crypts were then pelleted and resuspended in Matrigel (BD Biosciences) and overlaid with intestinal growth medium (Advanced DMEM/F12, N2, B27, 15 mM HEPES, 2 mM lglutamine, penicillinstreptomycin) supplemented with EGF (50 ng mL −1 ), Noggin (100 ng mL −1 ), Rspondin 1 (1 µg mL −1 ) (R&D Systems), 50% Wnt3a conditioned medium, 1 mM Nacetylcysteine, 10 nM (Leu15) Gastrin, 10 mM Nicotidamide, 10 µM SB202190 (SigmaAldrich), 500 nM A8301 (Tocris). 2.5 µM Thiazovivin and 2.5 µM CHIR99021 (Stemgent) npg were added to the medium for the first 2 d. Medium was changed every 3 d. Established enteroids were passaged over time by enzymatic (TrypLE Express, Life Technologies) and mechanical dissociation through an 18gauge needle after 7 d in culture. Dissociated enteroids were then resuspended in PBS and pelleted before resuspension in Matrigel and culture conditions as above.
Intestinal alkaline phosphatase activity. Frozen sections were washed in PBS and blocked using donkey serum. Sections were incubated with Permanent Red working solution (Permanent Red substrate + Permanent Red chromogen; Dako) for 30 min at room temperature. Sections were then washed in PBS and mounted for imaging.
In vivo FD4 permeability assay. FITCconjugated dextran (FD4; 4,400 MW; Sigma) was dissolved in sterile water at a final concentration of 20 mg ml −1 . Mice with previous transplants 8 weeks prior were then anesthetized as described above, and a left, posterior subcostal incision was made to expose the left kidney and engrafted intestinal tissue. Human engraftments were then injected each with 100 µL of FD4. Whole blood was then collected using heparinized hematocrit capillary tubes at time points 30 min and 4 h post injection, and fluorescence intensity in murine sera was analyzed using a fluo rescent plate reader. The concentration of FITCdextran was then determined by comparison to the FITCdextran standard curve dissolved in water.
In vivo tomato lectin injections. Fluorescein Lycopersicon esculentum (tomato) lectin (Vector laboratories) was resuspended in PBS at a final concentration of 2 mg ml −1 . 8 weeks after HIO transplantation, mice were placed under anesthesia as described above and were each injected with 200 µl of the tomato lectin via the tail vein. Mice were then humanely euthanized 30 min following injection, and tissues were collected for imaging.
In vivo D-Ala-Leu-Lys-AMCA uptake study. dAlaLeuLys7amido4 methylcoumarin (dAlaLeuLysAMCA; Sigma) was prepared as previously described 30 with modification for a final concentration of 25 µM solution in DMEM (Dulbecco's Modified Eagle Medium; Gibco). Mice were anesthetized as described above and a left posterior subcostal incision was created to expose the engraftment. The engraftment lumen was then injected with 100 µL of dAlaLeuLysAMCA, and mice were closed in a doublelayer fashion. Mice were euthanized 30 min postinjection, and tissue was collected for analysis. For comparison, engraftments were also injected with vehicle (DMEM solu tion) alone or with peptide solution mixed with 1 mM Captopril (Sigma), a competitive inhibitor of peptide uptake.
Tissue processing, immunofluorescence and microscopy. Tissues were fixed for 2 h to overnight in 4% paraformaldehyde (PFA). Organoid engraftments were frozen in OCT, whereas mouse intestinal tissues were embedded in par affin. OCT sections were blocked using donkey serum (10% serum in 1× PBS plus 0.5% TritonX) for 30 min and incubated with primary antibody overnight at 4 °C. Slides were then washed and incubated in secondary anti body in blocking buffer for 2 h at room temperature (23 °C). Paraffin sections were deparaffinized, subjected to antigen retrieval, and stained in a similar fashion to OCT sections. Please see Supplementary Table 1 for a list of anti bodies and respective dilutions. Slides were then washed and mounted using ProLong Gold antifade reagent with DAPI (Life Technologies). Images were captured on a Nikon Eclipse Ti and analyzed using Nikon Elements Imaging Software (Nikon). For transmission electron microscopy (TEM), tissues were fixed overnight in 3% glutaraldehyde in 0.175 M sodium cacodylate buffer pH 7.4. Samples were then post fixed in 1% Osmium tetroxide in 0.175 M cacodylate buffer for 1 h at 4 °C. Samples were washed and put through a series of graded ethanol (25, 50, 75 , 95, 2× 100%). Infiltration was performed with 2× Propylene Oxide followed by graded infiltration with LX112. Samples were placed in polymerization oven at 37 °C overnight and then kept at 60 °C for 3 d. A Hitachi H7600 transmission electron microscope was used to image TEM sections. For wholemount staining, tissues were processed similarly as above and then cleared in Murray's solution. Imaging was performed with a Nikon A1 confocal microscope.
RNA isolation and RT-qPCR. RNA was extracted using RNeasy Plus Mini Kit (Qiagen) according to manufacturer's protocols. A cDNA reverse transcrip tion kit (Applied Biosystems) was used to synthesize cDNA. Taqman (Applied Biosystems) gene expression assays were then performed on triplicate samples using a OneStep cycler (Applied Biosystems). See Supplementary Table 2 for a list of Taqman probes used.
Morphometric and statistical analyses. Histological sections were stained with hematoxylin and eosin or subjected to immunohistochemistry (as described above). All histological samples were counted in a blinded man ner. Crypt depth, villus height, and smooth muscle layer (tunica muscularis) thickness were measured for a minimum of 100 welloriented cryptvillus units or smooth muscle layer segments per mouse and then averaged using Nikon NIS imaging software. Crypt fission was also calculated in a similar manner using longitudinal sections to determine the percentage of fissioning crypts from at least 100 intact crypts per animal. A fissioning crypt is defined as a bifurcating crypt with a bisecting fissure creating two (or sometimes more) flaskshaped bases with a shared single cryptvillus junction ( Supplementary  Fig. 4a,f) 26 . Proliferative index was determined by injecting mice with 5ethynyl2′deoxyuridine (Edu) 2 h before killing, and then, following routine Edu immunohistochemistry according to manufacturer's instructions, proliferative index was determined by calculating the ratio of Edupositive cells to total cells within at least 10 intact crypts. All data are represented as mean ± s.e.m. ttests and twoway analysis of variance were completed using Prism (GraphPad). The determined significance cutoff was P < 0.05. No statistical method was used to predetermine sample size.
The experiments were not randomized except ICR experiments, where transplanted animals were randomly assigned to a sham or an ICR group. The investigators were not blinded to allocation during experiments and outcome assessment except for the morphometric analysis for the ICR experiments. 
